Lupus nephritis—winning a few battles but not the war
- 21 June 2011
- journal article
- Published by Springer Science and Business Media LLC in Nature Reviews Rheumatology
- Vol. 7 (8), 441-442
- https://doi.org/10.1038/nrrheum.2011.88
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- End-stage renal disease due to lupus nephritis among children in the US, 1995-2006Arthritis & Rheumatism, 2011
- Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006Arthritis & Rheumatism, 2011
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trialThe Lancet, 2011
- A decade of mycophenolate mofetil for lupus nephritis: is the glass half-empty or half-full?Annals Of The Rheumatic Diseases, 2010
- Confusion about the Appropriate Use of Erythropoiesis-Stimulating Agents in Patients Undergoing Maintenance DialysisSeminars in Dialysis, 2010
- Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus NephritisJournal of the American Society of Nephrology, 2009
- The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamideAnnals Of The Rheumatic Diseases, 2009
- Changes in the Incidence of Endstage Renal Disease Due to Lupus Nephritis in the United States, 1996–2004The Journal of Rheumatology, 2009
- EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including TherapeuticsAnnals Of The Rheumatic Diseases, 2007
- Changes in the Incidence of End-stage Renal Disease Due to Lupus Nephritis, 1982-1995Archives of Internal Medicine, 2000